Challenges of implementation. a regulatory perspective
|
|
- Kellie Carter
- 6 years ago
- Views:
Transcription
1 Challenges of implementation of ICH Q 9 a regulatory perspective Jacques Morénas Deputy Director Inspectorate and Companies Department The French Health Products Safety Agency (AFSSAPS) telephone : fax : jacques.morenas@afssaps.sante.fr sante fr International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
2 Disclaimer: The information within this presentation is based on the presenter's expertise and experience, and represents the views of the presenter for the purposes of a training workshop.
3 Quality Risk Management is not a single process Start Risk identification Subprocess Sub-Subprocess Start Feedback procedure Process- step Decision Start Risk analysis Etc. End End End
4 In front of that.. You could feel lonely
5 Agenda Principles and environment What is an acceptable risk to quality? Risk management approaches for companies Risk management approaches for regulators Changing periods
6 Agenda Principles and environment What is an acceptable risk to quality? Risk management approaches for companies Risk management approaches for regulators Changing periods
7 The hurdles Increasing external requirements for best practice, transparency and compliance Public / Community Governments Regulators Patients Investors / Creditors Increasing efforts and costs for sustainability? Documentation Projects Systems Interfaces Growing complexity and scope of risks Globalisation Multinational Multi-factor approaches Regulatory expectations ti Acceptance of risk and uncertainty
8 Today
9 Empowerment & flexibility An appropriate integrated approach help to meet requirements more efficiently i Proactive disclosure, build trust and understanding Quality Risk Management Improve communication through sharing best practice and integrating tools Master complexity and aggregation by providing tools and methodology
10 Vision of the future science-based & risk-based behavior
11 Incremental steps Changed Paradigm Pharmaceutical Development (Q8) Past: Data transfer / Variable output Future: Knowledge transfer / Consistent output Quality Risk Management (Q9) Q11 Past: Informal approach Future: Opportunity to use a structure and process thinking Q9 Pharmaceutical Quality Systems (Q10) Past: Large variability on Q-systems Future: Consistency on Q-systems
12 PAT ICH Q8 ICH Q10 Design space ICH Q11 ICH Q9 How industry will apply the (new) concepts? What will change?
13 Definitions Quality Risk & Management QRM Degree to which a set of inherent properties of a product, system or process fulfills requirements combination of the probability of occurrence of harm and the severity of that harm Systematic process for the assessment, control, communication and review of risks to the quality of the drug (medicinal) product across the product lifecycle
14 Product lifecycle for medicinal products Research Preclinical Phase Clinical Phases Launch GLP Safety Manufacturing GCP GMP Efficacy ICH Q9 Quality
15 Principles of Quality Risk Management Two primary principles: The evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient The level of effort, formality and documentation of the quality risk management process should be commensurate with the level of risk
16 A General Quality Risk Management Process Risk Comm munication Initiate Quality Risk Management Process Risk Assessment Risk Control Risk Identification Risk Analysis Risk Evaluation Risk Reduction Risk Acceptance unacceptable Risk Manage ementtools Team approach Output / Result of the Quality Risk Management Process Risk Review Review Events
17 What makes Q9 different? It provides principles p and a framework for decision making Q9 is a quality improvement methodology It is a guidance not an SOP Simple Flexible Not mandatory It supports science-based decision making Facilitates communication and transparency Supports build up trust Q9 is for both industry and competent authorities (CA)
18 Role of Quality Risk Management Product Development Process Development Conclusions & Tech. Transfer Commercial Manufacturing Product / prior Knowledge Manufacturing Process / prior Knowledge Product and Process Development Knowledge Process History for life cycle mgmt Risk Assessment Risk Assessment Risk Control Risk Review Excipient & Drug Subst. Design Space Manuf. Process Design Space Product quality & control strategy Opportunities to apply Quality Risk Management Continual Improvement Process understanding
19 Agenda Pi Principles i and environment What is an acceptable risk to quality? Risk management approaches for companies Risk management approaches for regulators Changing periods
20 What is an acceptable risk to quality? Decision i making activity it by the stakeholders. To be considered: Is the risk on an acceptable level? What can be done to reduce or eliminate risks? What is the appropriate balance between benefits, risks and resources? Do measurements introduce new risks?
21 What is an acceptable risk to quality? Who has to accept risk? Decision i maker(s) Person (s) with the competence and authority to make appropriate p and timely quality risk management decisions Decision makers might also be stakeholders Stakeholder Any individual, group or organization that can be affected by a risk The primary stakeholders are the patient, healthcare professional, regulatory authority, and industry
22 What is an acceptable risk to quality? This has to be decided in the context of each specific risk management problem Put in precise and definite data receive a clear answer Enable decision i makers to make good and transparent t decisions Accept risk, if the effort to reduce a risk will solve the specific problem. Keep in view: The protection of the patient It s up to the organization whether they accept risks that meet the principles of QRM
23 What is an acceptable risk to quality? An event Considerations: Industrial risk could be different from political risk Notion of "risk" could be not the same for industry and competed health authority (CA) CA are often face to face with public opinion and politicians Compromise according to ICH Q9: link back to the protection of the patient
24 What is a residual risk? Residual risk address hazards that have been assessed and risks that have been accepted that have not yet been identified which have been identified but the risks have not been correctly assessed which are not yet linked Is the risk transferred to an acceptable level? Consider current scientific knowledge & techniques Fulfil all legal and internal obligations As hazards remain zero risk is never possible
25 Risk acceptance as part of risk control Discuss the appropriate balance among benefits, risks, and resources Be careful to emphasize the principles: the patients interests and good science/data Risk acceptance is not: Inappropriately interpreting ti data and information Hiding risks from the regulators Dodging legal requirements See a possible decision tree in the back-up slides
26 Agenda Principles and environment What is an acceptable risk to quality? Risk management approaches for companies Risk management approaches for regulators Changing periods
27 Managing risks in a company Company Strategy risks Operational risks Financial risks Compliance risks Environmental Enterprise risk management Regulatory Quality / GMP
28 Existing organisation Operations Support Manufacturing Quality Unit Procurement etc Quality Management Quality Assurance Quality Control Validation Risk Management
29 How can Q9 be implemented? The ICH Q9 document: Main body explains the What? Annex I give ideas on the How? Annex II give ideas on the Where? It can be implemented by industry Pharmaceutical Development (ICH Q8) and Quality Systems (ICH Q10) will indicate the When? It helps prevent ent overly restrictive e and unnecessary requirements being imposed by either industry or regulators (ICH Q9)
30 How can Q9 be implemented? ICH Q9 Existing internal documentation system Where to be in future? (Mission, Policy) What to do? (e.g. Directives) How to do? (e.g. Guidelines) Detailed instructions (e.g. Standard Operating Procedures) Records Rules & Procedures (internal regulations) Records & Reports
31 When to use Quality Risk Management? Should risks be assessed? Are there clear rules for decision making? No 1. What might go wrong? 2. What is the likelihood (probability) it will go wrong? 3. What are the consequences (severity)? Yes no RM Can you answer the risk assessment questions? Yes informal RM No formal RM Agreeonateam (small project) Risk assessment not required (No flexibility) Initiate Risk assessment (risk identification, analysis & evaluation) Select a Risk Management tool (e.g. see ICH Q9 Annex I) Follow procedures (e.g. Standard Operating Procedures) Run risk control (select appropriate measures) Carry out on the Risk Management tool Document results, decisions and actions Document the steps
32 Contributing items to manage quality risks System Risk (facility & people): e.g. interfaces, operators risk, environment, components like: equipment, IT, design elements System Risk (organisation): e.g. quality systems, controls, measurements, documentation, regulatory compliance Process Risk: e.g. process operations and quality parameters Product Risk (safety & efficacy): e.g. quality attributes: measured data according to specifications
33 Agenda Pi Principles i and environment What is an acceptable risk to quality? Risk management approaches for companies Risk management approaches for regulators Changing periods
34 Implementation in assessment Evaluation of : Impact of proposed changes Impact of deviations i Impact of out of specification results EMA Process Analytical Technology (PAT) team involving assessors and GMP inspectors
35 Implementation in assessment Revised documents such as note for guidance for Real Time Release Testing (previously Parametric Release)
36 Implementation in inspection Three possible areas have been already identified: Planning of inspection Conducting an inspection Management of suspected quality defects
37 Planning of inspection Inspection frequency and depth should be adapted subject to (and for example) : * Examination of a site master file (if available) * Review of the products manufactured by the company * Review of the reports from previous inspections * Review of the follow-up actions (if any) arising from previous inspections * Review of product recalls initiated since the previous inspection an examination of relevant product defects notified since the previous inspection * Review of the analysis of any samples analyzed by the Competent Authority since the previous inspection Etc
38 Planning of inspection Categories Description Inspection intervals Poor compliance level The last inspection revealed major or critical deficiencies 6 X - 1 Acceptable compliance level Good compliance level The two last inspections have revealed no critical deficiency and less than 6 major deficiencies 2 The two last inspections have revealed no critical and no major deficiency X (= regulatory interval) X+1
39 Planning of inspection The objectives of Competent Authorities is to optimize the inspection resources Using both QRM and PQS (Pharmaceutical Quality System which could be ICH Q10), confidence between industry and GMP inspectors should be increased with an impact on inspection frequency and depth
40 Conducting an inspection How can QRM activity be inspected? If the company explains that ICH Q9 has been used as reference for establishing the QRM, it will be used by inspectors. If not, inspectors might review : Whether the quality risk management performed is integrated in the Quality System of the organization Traceability, transparency How was the decision made? Was a (risk) problem / question defined? Did the process performed answer this question? Were the appropriate functions allocated to all teams? Were the right documents recognized? Was the decision based on scientific knowledge?
41 Management of suspected quality defects Defining an SOP based on QRM principles for dealing with suspected quality defects
42 Agenda Pi Principles i and environment What is an acceptable risk to quality? Risk management approaches for companies Risk management approaches for regulators Changing periods
43 The ultimate goal of QRM Sharing information and ideas
44 QRM Communication facilitates trust and understanding di Regulators operation - Reviews - Inspections Industry operation - Submissions - Manufacturing
45 Integration of QRM A common understanding and application of quality risk management principles could facilitate mutual confidence and promote more consistent decisions among regulators on the basis of the same information. This collaboration could be important in the development of policies and guidelines that integrate and support quality risk management practices.
46 Lessons learned It is easy to use Quality Risk Management in supporting decision making How to prioritise work? What next? Quality Risk Management requires teamwork It seems to be time consuming No one says: It was a waste of time Aid for rationalisation of the decision For a better transparency Increasing transparency is often requested Is this relay the desired state?
47
GAMP 5 Quality Risk Management. Sion Wyn Conformity +[44] (0)
GAMP 5 Quality Risk Management Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 GAMP5 Key Concepts Life Cycle Approach Within a QMS Scaleable Life Cycle Activities Process and Product
More informationThe Role of Quality Risk Management in the Manufacture of Biological Products CBER Perspective
The Role of Quality Risk Management in the Manufacture of Biological Products CBER Perspective CASSS CMC Strategy Forum: Practical Applications of Quality Risk Management 27-28 28 July 2009 Nancy Waites
More informationRISK ASSESSMENT APPROACH AND ITS APPLICATION IN PHARMACEUTICAL INDUSTRY FOR PRODUCT QUALITY MANAGEMENT
Journal of Medical Pharmaceutical And Allied Sciences REVIEW ARTICLE RISK ASSESSMENT APPROACH AND ITS APPLICATION IN PHARMACEUTICAL INDUSTRY FOR PRODUCT QUALITY MANAGEMENT Singh U. K.* Pahwa Shilpa, Sethi
More informationPREP Course # 17 Compliance in Human Subject Research: Implementing Quality Systems. Office of Research Compliance. February 16 th, 2016
PREP Course # 17 Compliance in Human Subject Research: Implementing Quality Systems Office of Research Compliance February 16 th, 2016 1 CME Disclosure Statement The Northwell Health adheres to the ACCME
More informationBasics of Quality Risk Management. CBE Pty Ltd
Basics of Quality Risk Management CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written
More informationRisk Analysis and Management. May 2011 ISO 14971
Risk Analysis and Management Qsite May 2011 ISO 14971 1 Agenda Definitions Risk Management Development Phases Process Hazards Evaluation Residual Risk 2 Why Do We Need Risk Analysis 1. Quantify the risk
More informationMaster Class: Construction Health and Safety: ISO 31000, Risk and Hazard Management - Standards
Master Class: Construction Health and Safety: ISO 31000, Risk and Hazard Management - Standards A framework for the integration of risk management into the project and construction industry, following
More informationRisk Management Strategy
Risk Management Strategy 2016 2019 Version: 6 Policy Lead/Author & Deputy Director of Quality position: Ward / Department: Nursing Directorate Replacing Document: Version 5 Approving Committee Quality
More informationDefining Risk and Risk Levels
Defining Risk and Risk Levels Implementing ICH Q9 Quality Risk Management Gamal Amer, Ph.D. Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Why Risk Management
More informationProgress of the East African Community Medicines Registration Harmonization (EAC - MRH) Project
Progress of the East African Community Medicines Registration Harmonization (EAC - MRH) Project Background EAC Regional Cooperation on Health EAC Medicines Registration Harmonization (EAC-MRH) Project
More informationEuropean Railway Agency Recommendation on the 1 st set of Common Safety Methods (ERA-REC SAF)
European Railway Agency Recommendation on the 1 st set of Common Safety Methods (ERA-REC-02-2007-SAF) The Director, Having regard to the Directive 2004/49/EC 1 of the European Parliament, Having regard
More informationQuality Risk Management from Concept to Practical Strategies*
Quality Risk Management from Concept to Practical Strategies* H. Gregg Claycamp, Ph.D. Director Div. of Compliance Risk Management and Surveillance and Associate Director, CDER Office of Compliance gregg.claycamp@fda.hhs.gov
More informationWe will begin the web conference shortly. When you arrive, please type the phone number from which you are calling into the chat field.
Welcome We will begin the web conference shortly. When you arrive, please type the phone number from which you are calling into the chat field. To login to the audio portion of the web conference, dial
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10.12.2008 COM(2008) 665 final 2008/0260 (COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending, as regards pharmacovigilance,
More informationTOOL #15. RISK ASSESSMENT AND MANAGEMENT
TOOL #15. RISK ASSESSMENT AND MANAGEMENT 1. INTRODUCTION Assessing risks 121 is complex and often requires in-depth expertise and specialist knowledge spanning various policy fields. The purpose of this
More informationCommon Safety Methods CSM
Common Safety Methods CSM A common safety method on risk evaluation and assessment Directive 2004/49/EC, Article 6(3)(a) Presented by: matti.katajala@safetyadvisor.fi / www.safetyadvisor.fi Motivation
More informationQuality Risk Management for Quality system 辉瑞制药有限公司解馨
Quality Risk Management for Quality system 质量风险评估在质量保证体系中的应用 辉瑞制药有限公司解馨 Agenda Introduction to QRM The QRM Process The 10 step approach to QRM Case Studies Final Points Slide 2 QRM - What is it? Structured
More informationRisk-Based Compliance Handbook INTRODUCTION
Chapter1:Layout 1 29/5/08 10:11 Page 1 1 INTRODUCTION Paracelsus famously stated that all things are poison and not without poison; that only the dose makes a thing not a poison ( Alle Ding sind Gift und
More informationUse of QRM to Quantify Particulate Contamination Risks
Use of QRM to Quantify Particulate Contamination Risks PDA Ireland Chapter Quality Risk Management Seminar NIBRT Mount Merrion, Blackrock, Co. Dublin Chris Roberts Agenda Background Objective / Scope Execution
More informationRisk assessment and the choice of conformity assessment procedures in the EU. Nike Bönnen European Commission TBT Committee, Geneva, 13 June 2017
Risk assessment and the choice of conformity assessment procedures in the EU Nike Bönnen European Commission TBT Committee, Geneva, 13 June 2017 Outline Legal Basis for Risk Assessment in the EU regulatory
More informationBest Practices in Applying Medical Device Risk. Management Terminology
Best Practices in Applying Medical Device Risk Management Terminology Fubin Wu and Alan Kusinitz ANSI/AAMI/ISO 14971:2007 defines harm as physical injury or damage to the health of people, or damage to
More informationBest Practices in Applying Medical Device Risk Management Terminology
Best Practices in Applying Medical Device Risk Management Terminology Fubin Wu and Alan Kusinitz About the Authors gessnet.com Fubin Wu is cofounder of GessNet risk management software in Sacramento, CA.
More informationENTERPRISE RISK MANAGEMENT (ERM) POLICY Republic Glass Holdings Corporation. Purpose. Goals
Purpose This Enterprise Risk Management Policy (the ERM policy) provides the framework for managing risks across ( RGHC or the Company ). It contains the policies to guide employees, management and the
More informationPlanning the Risk Management File Audit
Planning the Risk Management File Audit This is a strategy to help prepare for a risk management file (RMF) audit. It incorporates requirements from the international standard ISO 14971:2007 as well as
More informationRisk Minimisation for Medicinal Products Part 2
Risk Minimisation for Medicinal Products Part 2 Contents Introduction...page 03 Module I Pharmacovigilance Systems and their Quality Systems...page 04 Module II Pharmacovigilance System Master File...page
More informationSCOTTISH FUNDING COUNCIL CAPITAL PROJECTS DECISION POINT PROCESS
SCOTTISH FUNDING COUNCIL CAPITAL PROJECTS DECISION POINT PROCESS Incorporating amendments by Scottish Futures Trust (Proposals for Decision Points 2 5 Only) Executive summary... 1 Section 1: Introduction
More informationRisk Management Framework
Risk Management Framework Anglican Church, Diocese of Perth November 2015 Final ( Table of Contents Introduction... 1 Risk Management Policy... 2 Purpose... 2 Policy... 2 Definitions (from AS/NZS ISO 31000:2009)...
More informationGUIDELINE ON THE PROCESSING OF RENEWALS IN THE MUTUAL RECOGNITION AND DECENTRALISED PROCEDURES
GUIDELINE ON THE PROCESSING OF RENEWALS IN THE MUTUAL RECOGNITION AND DECENTRALISED PROCEDURES 1. Introduction Final REV 1 October 2005 This paper considers issues associated with the processing of renewals
More informationSeptember 21, Panelists: Scott Soukup, Quality Specialist, RCA Inc. Joan M. Ward, Quality Subject Matter Expert, RCA Inc.
Conducting CAPA Investigations September 21, 2016 Panelists: Scott Soukup, Quality Specialist, RCA Inc. Joan M. Ward, Quality Subject Matter Expert, RCA Inc. Moderator and Panelist: Susan Schniepp, Distinguished
More informationSecurity Risk Management
Security Risk Management Related Chapters Chapter 53: Risk Management Also Chapter 32 Security Metrics: An Introduction and Literature Review Chapter 62 Assessments and Audits 2 Definition of Risk According
More informationWelcome. AMCP Partnership Forum. Designing Benefits and Payment Models for Innovative High Investment Medications
AMCP Partnership Forum Designing Benefits and Payment Models for Innovative High Investment Medications Welcome Bri Palowitch, PharmD, BCGP Manager, Pharmacy Affairs Academy of Managed Care Pharmacy Disclaimer
More informationHow to demonstrate foreign building compliance with drug good manufacturing practices
How to demonstrate foreign building compliance with drug good manufacturing practices GUI-0080 January 18, 2018 How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080)
More informationLIFE CYCLE ASSET MANAGEMENT. Project Management Overview. Good Practice Guide GPG-FM-001. March 1996
LIFE YLE Good Practice Guide ASSET MANAGEMENT Project Management Overview March 1996 Department of Energy Office of Field Management Office of Project and Fixed Asset Management ontents 1. INTRODUTION...1
More informationRISK MANAGEMENT STRATEGY Version 3
RISK MANAGEMENT STRATEGY Version 3 Risk Management Strategy V3 - March 2018 1 Standard Operating Procedure St Helens CCG Risk Management Strategy Version 3.0 Implementation Date September 2014 Review Date
More informationStreamlining Risk Management Evaluations for New Manufacturing Processes
May 1-3, 2012 Javits Center New York, NY Streamlining Risk Management Evaluations for New Manufacturing Processes Mike Porter Consultant Commissioning Agents, Inc. Title Date Javits Center New York, NY
More informationHealth Purchasing Victoria Benefits Management Framework 2018
Health Purchasing Victoria Benefits Management Framework 2018 30 May 2018 Version 1.0 DRAFT HPV Benefits Management Framework 2018 30 May 2018 1 Author John Delinaoum Version 1.0 Implementation Approval
More information4. Environmental insurance as an environmental policy tool: research concept and approach
4. Environmental insurance as an environmental policy tool: research concept and approach As discussed in Chapter 3, insurance can be an effective means to provide financial security with risk spreading,
More informationTo err is human. Pete Davis VP of Research & Development Neomend a subsidiary of Bard Davol
To err is human Pete Davis VP of Research & Development Neomend a subsidiary of Bard Davol 1 Really an R&D guy presenting risk analyses?? 2 Risks exist because perfection doesn t! 3 Communicating to Management
More informationOPERATIONAL INSTRUCTION REF. OI.IPMG ACCEPTANCE OF ENGAGEMENT AGREEMENTS
Headquarters, Copenhagen 3 April 2018 OPERATIONAL INSTRUCTION REF. OI.IPMG.2018.02 ACCEPTANCE OF ENGAGEMENT AGREEMENTS 1. Authority 1.1. This Operational Instruction (OI) is promulgated by the Director
More informationConcepts in Risk-based Assessment Risk in Medical Imaging Ehsan Samei, PhD. Outline. Outline 8/3/2016
Concepts in -based Assessment in Medical Imaging Ehsan Samei, PhD Outline Why of talk about risk? Science of risk and risk assessment in imaging Radiation risk in terms of patient welfare Outline Why of
More informationIntroduction. The Assessment consists of: A checklist of best, good and leading practices A rating system to rank your company s current practices.
ESG / CSR / Sustainability Governance and Management Assessment By Coro Strandberg President, Strandberg Consulting www.corostrandberg.com September 2017 Introduction This ESG / CSR / Sustainability Governance
More informationPost Market Surveillance & Vigilance - the way towards harmonisation-
Post Market Surveillance & Vigilance - the way towards harmonisation- Chadaporn (Miang) Tanakasemsub AHWP TC WG02 co-chair GHTF SG2 member Regional QA/RA director, Asia Pac Zimmer Asia Pacific 1 What is
More informationPHARE 2005 / Project: «Contributions to the development
PHARE 2005 / 017 690.01.01 Project: «Contributions to the development of the Flood Risk Management Strategy in Romania» EuropeAid/123064/D/SER/RO Euro RIOB 2008 : «Floods Directive» 2 October 2008 Agenda
More informationEGA S COMMENTS ON THE CONCEPT PAPER ON THE INTRODUCTION OF FEES TO BE CHARGED BY THE EMA FOR PHARMACOVIGILANCE.
EGA S COMMENTS ON THE CONCEPT PAPER ON THE INTRODUCTION OF FEES TO BE CHARGED BY THE EMA FOR PHARMACOVIGILANCE. EGA S COMMENTS ON THE CONCEPT PAPER SUBMITTED FOR PUBLIC CONSULTATION ON THE INTRODUCTION
More informationEnergize Your Enterprise Risk Management
Energize Your Enterprise Risk Management Presented By Mark Caiazzo, CISA, CISM, CRISC Tammy Michaud, CPA May 15, 2017 Reviewed: Agenda Enterprise Risk Management Defined Benefits of ERM Key Components
More informationCONCEPT OF RISK ASSESSMENT FOR ESTONIAN OIL SHALE MINES RISKA NOVĒRTĒŠANAS JĒDZIENS IGAUNIJAS DEGSLĀNEKĻA RAKTUVĒS
CONCEPT OF RISK ASSESSMENT FOR ESTONIAN OIL SHALE MINES RISKA NOVĒRTĒŠANAS JĒDZIENS IGAUNIJAS DEGSLĀNEKĻA RAKTUVĒS JYRI-RIVALDO PASTARUS, SERGEI SABANOV Tallinn University of Technology, Department of
More informationCMP for Special Regs and Safety Issues. 1. INTRODUCTION Purpose Scope Submissions to Australian Sailing:...
CMP Policy - AS i Australian Sailing CMP for Special Regs and Safety Issues 1. INTRODUCTION... 1 1.1. Purpose... 1 1.2. Scope... 1 1.3. Submissions to Australian Sailing:... 1 2. CHANGE MANAGEMENT PROCEDURE
More informationDivision for Europe STRATEGY FOR THE TECHNICAL COOPERATION PROGRAMME IN THE EUROPE REGION
Division for Europe STRATEGY FOR THE TECHNICAL COOPERATION PROGRAMME IN THE EUROPE REGION (As adopted at the Europe Region National Liaison Officers Meeting, Vienna, Austria, on 19 February 2010) I. BACKGROUND
More informationCOMPROMISE AMENDMENTS 1-8
EUROPEAN PARLIAMT 2009-2014 Committee on Industry, Research and Energy 2013/0340(NLE) 7.3.2014 COMPROMISE AMDMTS 1-8 Draft report Romana Jordan (PE526.123v02-00) on the proposal for a Council directive
More informationUL REGISTRAR PHARMACEUTICAL DRUG AUDIT TOOL RISK ASSESSMENT
UL REGISTRAR PHARMACEUTICAL DRUG AUDIT TOOL RISK ASSESSMENT UL GMP CERTIFICATION PROGRAM Accreditation BENEFITS Globally, UL Registrar LLC (UL) is Accredited by the American National Standards Institute
More informationReport of East African Community Benchmarking visit to the European Medicines Agency, May 2017
10 July EMA/438768/ Report of East African Community Benchmarking visit to the European Medicines Agency, 18-19 May Part of the East African Community Medicines Regulatory Harmonization (EAC-MRH) Project
More informationBenefit Package Design for UHC: The case of Indonesia
Welcome to the webinar Benefit Package Design for UHC: The case of Indonesia organized by Deutsche Gesellschaft für Internationale Zusammenarbeit, GIZ socialprotection.org presents the webinar Benefit
More informationCommon Safety Method (CSM) for risk assessment (Regulations 352/2009 & 402/2013)
Common Safety Method (CSM) for risk assessment (Regulations 352/2009 & 402/2013) inland transport of dangerous goods - Lille, 8-9 th October 2013 E-mail: CSM.risk_assessment@era.europa.eu Slide n 1 Introduction
More information1. INTRODUCTION. Activity A of the WHO Member State Mechanism November 2017
RECOMMENDATIONS FOR HEALTH AUTHORITIES ON CRITERIA FOR RISK ASSESSMENT AND PRIORITIZATION OF CASES OF UNREGISTERED/UNLICENSED, SUBSTANDARD AND FALSIFIED MEDICAL PRODUCTS 1. INTRODUCTION Activity A of the
More informationLoss Prevention Strategy & Framework for Manitoba Public Insurance
Loss Prevention Strategy & Framework for Manitoba Public Insurance May Version:. Date Revised: May, Document Name: MAIN_MPI Loss Prevention Strategy and Framework.docx Page 0 Executive Summary Manitoba
More informationAir Traffic Organization Policy. Air Traffic Organization Safety Management System
Air Traffic Organization Policy ORDER JO 1000.37 Effective Date: March 19, 2007 SUBJ: Air Traffic Organization Safety Management System The purpose of the Air Traffic Organization (ATO) is to provide a
More informationDocumentation Control. Hazard Identification, Risk Assessment and Management Procedure. (This document is linked GG/CM/007- Risk Management Policy)
Documentation Control Reference: Date approved: 24 November 2016 Approving Body: (This document is linked GG/CM/007- Risk Management Policy) Trust Board (Medical Director) Implementation Date: 24 November
More informationCONTROLLED DOCUMENT. Version Number: 4.1. On: January 2018 Review Date: June 2016 Distribution: Essential Reading for: Information for: 1 of 15
Risk Management Strategy and Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE: Controlled Number: Document Strategy/Policy Governance To set out the principles and framework for the management
More informationPRINCE2 Sample Papers
PRINCE2 Sample Papers The Official PRINCE2 Accreditor Sample Examination Papers Terms of use Please note that by downloading and/or using this document, you agree to comply with the terms of use outlined
More informationRisk Assessment for Drug Products with Device Components
Risk Assessment for Drug Products with Device Components Khaudeja Bano, M.D. Senior Medical Director, Medical Device Safety Head, Pharmacovigilance and Patient Safety AbbVie Inc. Process consisting of:
More informationWSSCC, Global Sanitation Fund (GSF)
Annex I WSSCC, Global Sanitation Fund (GSF) Terms of Reference Country Programme Monitor (CPM) BURKINA FASO 1 Background The Water Supply and Sanitation Collaborative Council (WSSCC) was established in
More informationPolicy No. Contact Brian Orpin Version 3.0 Issue Date 28/11/2014 Telephone Review Date IA Date 09/08/2013
Information Governance Management of Risk Policy Policy No. Contact Brian Orpin Version 3.0 Email Brian.orpin@nhs.net Issue Date 28/11/2014 Telephone 0131 314 5360 Review Date IA Date 09/08/2013 Change
More informationHEALTH RESEARCH CAPACITY STRENGTHENING INITIATIVE. Program Risk Management Policy. September Imperial : +265 (0)
HEALTH RESEARCH CAPACITY STRENGTHENING INITIATIVE Program Risk Management Policy September 2012 Imperial : +265 (0) 111 924 335 Appendix II: Final Rating The rating for the Likelihood shall be multiplied
More informationNHS BROMLEY CLINICAL COMMISSIONING GROUP RISK MANAGEMENT STRATEGY
NHS BROMLEY CLINICAL COMMISSIONING GROUP RISK MANAGEMENT STRATEGY 1 CONTENTS Page Number Introduction 3 Purpose 4 Objectives 4 Systematic Approach to Risk Management 4 The Risk Management Structure 5 Risk
More informationTransparency. & Trust Tenth Annual Pharmaceutical Regulatory & Compliance Congress & Best Practices Forum
Transparency & Trust Tenth Annual Pharmaceutical Regulatory & Compliance Congress & Best Practices Forum 11,11,2009 Track III Transparency & third-part compliance Requirements Pubic Affairs & Corporate
More informationMinistry of Health / Ministry of Finance Toolkit
Ministry of Health / Ministry of Finance Toolkit December 11, 2014 Montreux, Switzerland Abt Associates Inc. In collaboration with: Broad Branch Associates Development Alternatives Inc. (DAI) Futures Institute
More informationFOOD SAFETY RISK ANALYSIS
Appendix D FOOD SAFETY RISK ANALYSIS 1.0 RISK IN FOOD PROCESSING 1.1 Risk Analysis 1.2 Risk Assessment 1.3 When to do a Risk Assessment 1.4 Risk Assessment and HACCP 1.5 The Health Risk Assessment Model
More informationCanada Life Investments
Canada Life Investments Order Execution Policy Owner Delegated Owner/s Last Approved 23 February 2018 Next Review Due Q1 2019 Version Number V1 2018 David Marchant, Managing Director & Chief Investment
More informationAPPENDIX 1. Transport for the North. Risk Management Strategy
APPENDIX 1 Transport for the North Risk Management Strategy Document Details Document Reference: Version: 1.4 Issue Date: 21 st March 2017 Review Date: 27 TH March 2017 Document Author: Haddy Njie TfN
More informationViewpoint Results Summary. Bank of England October 2017
Viewpoint 2017 Results Summary Bank of England October 2017 Overview: Understanding how employees feel about working in the Bank is of huge importance to the Governors and senior management. Between 5
More informationMarket Access Strategy and Planning: Succeeding in the Age of Value-based Reimbursement
Market Access Strategy and Planning: Succeeding in the Age of -based Reimbursement Presented by: Michael J. Lacey, Senior Director, Strategic Consulting (Life Sciences) Date: March 01, 2017 Truven Health
More informationOverview of Pharmaco- Economics Methodologies Maher Hassoun, M.S.
Overview of Pharmaco- Economics Methodologies Maher Hassoun, M.S. Director of Communications, ISPOR Lebanon Chapter (LSPOR) ISPOR Member Country Manager, Mundipharma Lebanon and Jordan Outline Current
More informationISO INTERNATIONAL STANDARD. Medical devices Application of risk management to medical devices
INTERNATIONAL STANDARD ISO 14971 Second edition 2007-03-01 Corrected version 2007-10-01 Medical devices Application of risk management to medical devices Dispositifs médicaux Application de la gestion
More informationASSESSING THE ROBUSTNESS OF A QUALITY RISK MANAGEMENT PROGRAM
ASSESSING THE ROBUSTNESS OF A QUALITY RISK MANAGEMENT PROGRAM Amanda Bishop McFarland Senior Quality Risk Management and Microbiology Consultant ValSource, LLC. ABOUT AMANDA & HOME SWEET HOME Cary, North
More informationResearch governance and Site specific assessment. Process and practice
Research governance and Site specific assessment Process and practice Research governance and Site specific assessment Process and practice If you would like to receive this publication in an accessible
More informationRISK MANAGEMENT and ISO 17025:2017
RISK MANAGEMENT and ISO 17025:2017 Dr. Bill Hirt Global Technical Advisor ANAB / ANSI-ASQ National Accreditation Board January 31, 2018 Outline of Sections Introduction of ANAB Risk management consistency
More informationCanada. 1. Noteworthy practices for project preparation. Case Study
Case Study Canada 1. Noteworthy practices for project preparation EXISTING ENABLING ENVIRONMENT Decentralised planning process with strong collaboration between provincial levels and the national government
More informationSECTORAL ANNEX ON GOOD MANUFACTURING PRACTICE (GMP) FOR MEDICINAL PRODUCTS PART A
SECTORAL ANNEX ON GOOD MANUFACTURING PRACTICE (GMP) FOR MEDICINAL PRODUCTS PART A 1. This Sectoral Annex applies to: the confirmation of the compliance with GMP requirements of manufacturing facilities
More informationChallenges in Reimbursing Orphan Medicinal Products. Evaluating Benefit, Determining a Fair Price and Optimizing Access
Challenges in Reimbursing Orphan Medicinal Products Evaluating Benefit, Determining a Fair Price and Optimizing Access Acknowledgements This presentation reflects the work of colleagues at the Department
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 26 March 2014
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products Quality, safety and efficacy PHARM 644 PHARMACEUTICAL COMMITTEE 26 March 2014 Subject: Implementation
More informationClaims Policy. Choice, Responsiveness, Integration & Shared Care
Claims Policy Choice, Responsiveness, Integration & Shared Care Worcestershire Mental Health Partnership NHS Trust Information Reader Box Document Type: Document Purpose: Unique identifier: Title: Target
More informationRisk Management Plan for the <Project Name> Prepared by: Title: Address: Phone: Last revised:
for the Prepared by: Title: Address: Phone: E-mail: Last revised: Document Information Project Name: Prepared By: Title: Reviewed By: Document Version No: Document Version Date: Review Date:
More informationThe JAMS COI Management Guidance on Eligibility Criteria for Clinical Practice Guideline Formulation March, 2017
The JAMS COI Management Guidance on Eligibility Criteria for Clinical Practice Guideline Formulation March, 07 Table of Contents. Background. Those subject to COI management. Disclosure items and self-disclosure
More informationBudgeting and Rolling Forecasting
Budgeting and Rolling Forecasting Accounting for Management Control September 29, 2015 Agenda Traditional annual budgeting Remedies to budgeting problems Rolling forecasting Relative targets Why to forecast
More informationRisk Management Policy
Risk Management Policy October 2014 Risks 1. Risks can be identified under four principal headings a. Financial risks b. Strategic Risks c. Operational Risks, and d. Hazard Risks 2. These are either externally
More informationCall for Tender - External Evaluation of the EPF 2017 Work Programme 16/03/2017
Call for Tender - External Evaluation of the EPF 2017 Work Programme 16/03/2017 Contents 1. Purpose of the tender... 3 2. Tasks... 4 3. EPF - General Information... 4 4. Description of services... 5 5.
More informationZurich Hazard Analysis (ZHA) Introducing ZHA
Introducing ZHA March 8, 2019 21st Annual Master Property Program Annual Loss Control Workshop Michael Fairfield, CSP Zurich North America - Risk Engineering Introducing ZHA Objectives After this introduction,
More informationRisk Assessment Policy
Risk Assessment Policy Updated: April 2018 Date of next Review: April 2019 Policy Lead: Bursar Checked by: Middle Leadership Team 1. INTRODUCTION Beachborough School will have hazards which if not controlled
More informationProgramming Documents Management Board meeting 12 December 2017
Programming Documents 2018-2021 Management Board meeting 12 December 2017 PRESENTATION SUMMARY Timeline, structure & content Key trends & resources outlook Highlights by strategic objective 2 TIMELINE
More informationLast update: Document reference: IMI2/INT/
Last update: 07.04.2017 Document reference: IMI2/INT/2017-00830 1 Contents 1 Legal and financial framework... 3 2 IMI partners and actitivities... 4 3 Factsheet - IMI at a glance... 5 4 Budgetary principles...
More informationOVERVIEW OF RISK ANALYSIS. APEC workshop: Hot Issues in Risk Analysis August 1, Singapore
OVERVIEW OF RISK ANALYSIS APEC workshop: Hot Issues in Risk Analysis August 1, 2009 - Singapore Risk Risk is everywhere Some risks more serious than others Zero risk is not an option Is unavoidable Is
More informationSection Defining Risk Management. 11. Principles of Risk Management
Section 2 10. Defining Risk Management Enterprise risk management is the process, affected by an entity's board of directors, management and other personnel, applied in strategy setting and across the
More informationRISK MANAGEMENT ANNUAL REPORT 2016/2017
RISK MANAGEMENT ANNUAL REPORT 2016/2017 Lead Executive Director Dr Iain Wallace, Medical Director Report Prepared By Mrs Carol McGhee, Corporate Risk Manager Approved By Corporate Management Team May 2017
More informationDefinitions of Serious Adverse Events are supplied in Appendix 1. See also ICH: GCP E6 and ICH E2A for further reference
Page 1 of 7 Table of Contents Page Policy 1 Procedures 2 Reporting Internal SAEs 2 Reporting External SAEs 2 Other Safety Reports 3 REB Acknowledgement of Receipt 3 References 3 Appendix 1 Definitions
More informationRisk Management & FMEAs. By Jay P. Patel, ASQ Fellow CEO & President QPS Institute
Risk Management & FMEAs By Jay P. Patel, ASQ Fellow CEO & President QPS Institute Learning Objectives Understand Risk management process elements Learn the principles involved in the Risk process Know
More informationFundamentals of Project Risk Management
Fundamentals of Project Risk Management Introduction Change is a reality of projects and their environment. Uncertainty and Risk are two elements of the changing environment and due to their impact on
More informationMONITORING THE COUNCIL S INVESTMENTS
MONITORING THE COUNCIL S INVESTMENTS Reducing Risk in Council Business Welcome! This presentation was developed jointly by the Information and Technical Assistance Center for Councils on Developmental
More informationUNITED NATIONS JOINT STAFF PENSION FUND. Enterprise-wide Risk Management Policy
UNITED NATIONS JOINT STAFF PENSION FUND Enterprise-wide Risk Management Policy 15 April 2016 Page 1 Table of Contents Page Preface I. Introduction 3 II. Definition 4 III. UNSJFP Enterprise-wide Risk Management
More informationExecutive Summary The Chal enge - Lives Are at Stake The JPIAMR The key to turn the tide of AMR
0 Executive Summary The Challenge - Lives Are at Stake Antibiotics have saved millions of lives throughout the many decades it has been in use as a common drug. However, antibiotic resistance is now a
More informationRisk Management Policy
Risk Management Policy Contents Executive summary... 3 Aim & introduction... 3 Definitions... 3 Consequence... 3 Event... 3 Likelihood... 3 Risk... 4 Risk Appetite... 4 Risk Management... 4 Risk Management
More information